Cliff Asness’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
29,172
+10,782
+59% +$613K ﹤0.01% 2622
2026
Q1
$1.18M Sell
18,390
-6,283
-25% -$573K ﹤0.01% 2670
2025
Q4
$3.21M Sell
24,673
-4,068
-14% -$558K ﹤0.01% 1836
2025
Q3
$3.1M Buy
28,741
+5,030
+21% +$548K ﹤0.01% 1724
2025
Q2
$2.19M Sell
23,711
-1,348
-5% -$106K ﹤0.01% 1722
2025
Q1
$2.22M Sell
25,059
-32,472
-56% -$2.82M ﹤0.01% 1553
2024
Q4
$4.42M Sell
57,531
-29,859
-34% -$2.09M 0.01% 1156
2024
Q3
$3.71M Buy
+87,390
New +$2.95M 0.01% 1197
2023
Q3
Sell
-19,438
Closed -$116K 2393
2023
Q2
$116K Buy
+19,438
New +$154K ﹤0.01% 2132
2022
Q4
Sell
-975
Closed -$28K 2289
2022
Q3
$28K Buy
975
+393
+68% +$18K ﹤0.01% 2161
2022
Q2
$24K Hold
582
﹤0.01% 2159
2022
Q1
$59K Buy
+582
New +$64.7K ﹤0.01% 2179

Other funds holding WGS

Cliff Asness's WGS Position: Q2 2026 in Review

Cliff Asness increased its GeneDx Holdings (WGS) stake by 59% in Q2 2026, buying an estimated $613K and bringing the position to 29,172 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Cliff Asness first reported a position in WGS in Q1 2022 and has held it in 12 quarters since. The position peaked at $4.42M in Q4 2024. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Cliff Asness held 29,172 shares of GeneDx Holdings worth $2M as of Q2 2026.
  • Cliff Asness bought 10,782 GeneDx Holdings shares in Q2 2026, an estimated $613K.
  • GeneDx Holdings made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2622 holding.
  • Cliff Asness first reported a position in GeneDx Holdings in Q1 2022 and has held it in 12 quarters since.
  • Cliff Asness's GeneDx Holdings position peaked at $4.42M in Q4 2024.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.